Ashley Leech, Ph.D., MS

Assistant Professor
Health Policy
Office Address
2525 West End Ave
Suite 1275
(615) 875-9642

Pregnancy/postpartum and infant health, substance use disorders, cost-effectiveness analysis/simulation modeling, perinatal pharmacoepidemiology

Ashley Leech is an Assistant Professor in the Department of Health Policy at the Vanderbilt University School of Medicine. Dr. Leech’s research answers questions related to healthcare access, delivery, resource allocation and use, and outcomes for reproductive-age individuals and their infants. She is the Principal Investigator of an NIH/NIDA-funded career development award on Advancing Treatment Outcomes for Pregnant Individuals with Opioid Use Disorder. In this role, she is employing decision science methodology to quantify the effects of treatment for opioid use disorder during the perinatal/postpartum periods on both immediate and long-term outcomes for pregnant individuals and their infants. 

Dr. Leech completed her post-doctoral training in Health Economics at the Center for the Evaluation of Value and Risk in Health (CEVR) at Tufts University School of Medicine where she focused on decision science methodology and received her Ph.D. in Health Services Research at Boston University School of Public Health.


Recent & Highlighted Research

Leech AA, McNeer E, Roberts AW, Dusetzina SB, Lai P, Morgan JR, Patrick SW. Buprenorphine Out-of-Pocket Costs and Discontinuation in Privately Insured Adults With Opioid Use Disorder. JAMA Intern Med. 2023 August 07. doi:10.1001/jamainternmed.2023.2826PubMed PMID: 37548972 Citation in REDCap PMC10407758.

Boos EW, Horta M, Thompson I, Dusetzina SB, Leech AA. Trends in the Use of Mifepristone for Medical Management of Early Pregnancy Loss From 2016 to 2020. JAMA. 2023 July 21. doi:10.1001/jama.2023.13628PubMed PMID: 37477929 Citation in REDCap

Leech AA, McNeer E, Stein BD, Richards MR, McElroy T, Dupont WD, Patrick SW. County-level Factors and Treatment Access Among Insured Women With Opioid Use Disorder. Med Care. 2023 May 18. doi:10.1097/MLR.0000000000001867PubMed PMID: 37199507 Citation in REDCap

Baig K, Dusetzina SB, Kim DD, Leech AA. Medicare Part D Coverage of Antiobesity Medications - Challenges and Uncertainty Ahead. N Engl J Med. 2023 March 16; 388(11):961-963. doi:10.1056/NEJMp2300516PubMed PMID: 36912541 Citation in REDCap

Leech AA, Lin PJ, D'Cruz B, Parsons SK, Lavelle TA. Family Spillover Effects: Are Economic Evaluations Misrepresenting the Value of Healthcare Interventions to Society?. Appl Health Econ Health Policy. 2023 January; 21(1):5-10. doi:10.1007/s40258-022-00755-8PubMed PMID: 35997896 Citation in REDCap PMC9839569.